An SP1-Binding Site and TATA Element Are Sufficient to Support Full Transactivation by Proximally Bound NS1 Protein of Minute Virus of Mice  by Lorson, Christian et al.
An SP1-Binding Site and TATA Element Are Sufficient to Support Full Transactivation
by Proximally Bound NS1 Protein of Minute Virus of Mice
Christian Lorson,1,2 James Pearson,1 Lisa Burger, and D. J. Pintel3
Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri-Columbia, Columbia, Missouri 65212
Received August 29, 1997; accepted November 9, 1997
The minute virus of mice (MVM) P38 Sp1-binding site and TATA box, inserted in an otherwise heterologous plasmid
background, could be transactivated to high levels by the MVM NS1 protein targeted proximally to these sequences,
demonstrating that these core promoter regulatory elements are sufficient to support essentially wild-type levels of
NS1-transactivated expression and suggesting that NS1 may act directly or indirectly with Sp1 and or elements of the general
transcription machinery. Accordingly, we show that bacterially generated NS1 can interact strongly, independent of nucleic
acid bridging, and most likely directly with Sp1 in vitro and can associate, in a nucleic acid-independent manner, with
endogenous Sp1 as it exists in a complex transcriptionally active murine nuclear extract. NS1 achieves the same fold
activation of an isolated TATA element over its low basal level and can also be demonstrated to interact efficiently and
specifically with the general transcription factors TBP and TFIIA (a, b) in vitro. © 1998 Academic Press
INTRODUCTION
The minute virus of mice (MVM) 5-kb single-stranded
DNA genome is organized into two overlapping tran-
scription units, with promoters at map units 4 (P4) and 38
(P38) (Astell et al., 1986; Pintel et al., 1983). The P4
promoter generates mRNAs R1 and R2, which encode
the nonstructural proteins NS1 and NS2, respectively,
while the P38 promoter generates the R3 mRNAs, which
encode the viral capsid proteins VP1 and VP2 (Astell et
al., 1986; Pintel et al., 1983; Cotmore and Tattersall,
1986a; Labieniec-Pintel and Pintel, 1986).
NS1, an 83-kDa nuclear phosphoprotein (Cotmore and
Tattersall, 1986a,b), is an essential multifunctional pro-
tein which regulates numerous aspects of the viral life
cycle. NS1 is required for viral DNA replication (reviewed
in Cotmore and Tattersall, 1995), viral gene expression,
and MVM-induced cytotoxicity (reviewed in Vanacker
and Rommelaere, 1995). NS1 has also been shown to
possess ATPase (Jindal et al., 1994; Nu¨esch et al., 1992),
helicase (Jindal et al., 1994; Nu¨esch et al., 1992), and
site-specific nicking activity (Cotmore and Tattersall,
1992; Cotmore et al., 1993) and is found covalently at-
tached to the 59 end of intracellular replicating viral DNA
(Cotmore and Tattersall, 1988; Nu¨esch et al., 1995). NS1,
in addition, binds DNA in a sequence-specific manner
(Cotmore et al., 1995; Christensen et al., 1995), recogniz-
ing the consensus (ACCA)1–3 motif which occurs at mul-
tiple positions throughout the MVM genome.
P38 basal expression, within the context of the com-
plete genome, occurs at such low levels as to be unde-
tectable by RNase protection assays (Naeger et al., 1992;
Lorson and Pintel, 1997; Lorson et al., 1996); however,
when NS1 is supplied in trans, P38 expression reaches
levels approximately twice those of P4 levels late in
infection (Schoborg and Pintel, 1991; Lorson and Pintel,
1997). Full NS1-transactivated levels require the P38 Sp1
and TATA elements (Ahn et al., 1992; Gavin and Ward,
1990; Gu et al., 1992; Lorson et al., 1996; Storgaard et al.,
1993; Christensen et al., 1993) and binding by NS1 to
either the TAR element or other functionally redundant
(ACCA)2 motifs present in cis (Lorson et al., 1996). A
small subgenomic MVM-P38 cassette [MVM nucleotide
(nt) 1866 to 1990], which exhibits no detectable basal
activity by RNase protection analysis, can be transacti-
vated by NS1 to essentially wild-type levels (Lorson et al.,
1996), suggesting that all the elements required for P38
transactivation are contained within this region.
NS1 has proven to be a potent transcriptional activa-
tor, primarily of P38, although it has also been reported to
activate heterologous promoters (Legendre and Rom-
melaere, 1994; Vanacker et al., 1996). The amino- and
carboxy-terminal domains of NS1, which contain numer-
ous acidic residues, have been implicated in maximal
transactivation of P38 (Legendre and Rommelaere, 1992).
While numerous mutations throughout NS1 effect the
ability of NS1 to transactivate transcription (Tullis et al.,
1988; Skiadopoulos and Faust, 1993; Jindal et al., 1994;
Nu¨esch et al., 1992), the NS1 C-terminal region, when
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fused to a heterologous DNA-binding domain, specifi-
cally and efficiently activates targeted promoters,
thereby identifying a potent modular activation domain in
this region of the molecule (Legendre and Rommelaere,
1994). The mechanism(s) of NS1 transactivation, how-
ever, has yet to be characterized.
Previous analysis, which concluded that a NS1:Sp1
interaction was required to bind NS1 to the P38 promoter
region, was based on the premise that NS1 lacked se-
quence-specific DNA-binding activity (Krady and Ward,
1995). It has subsequently been shown that NS1 has
sequence-specific DNA-binding activity (Cotmore et al.,
1995; Christensen et al., 1995), and transactivation of the
P38 promoter requires proximal DNA binding by NS1
(Lorson et al., 1996). In this report we demonstrate that
core promoter regulatory elements (Sp1 and TATA) com-
prise the minimal constituents of a fully NS1-responsive
promoter. Positioning either a synthetic NS1-binding mo-
tif (ACCA)4 or the native transactivation response ele-
ment (TAR) upstream of isolated Sp1 and TATA elements
resulted in efficient NS1 transactivation and suggested
further that NS1 may interact with the cellular factors that
associate with these two cis elements, namely Sp1 and
members of the general transcription factors (GTFs).
Accordingly, we demonstrate NS1 and Sp1 can directly
interact, extending the work of Krady and Ward (1995)
who showed that NS1 and Sp1 can participate in com-
plex formation. Using a more sensitive reporter assay,
we also demonstrate that NS1 can achieve a similar fold
activation of an isolated TATA element, over its low basal
level, and we identify two additional proteins that interact
with NS1 in vitro: TFIIA(a/b) and TBP.
RESULTS AND DISCUSSION
The core promoter elements are sufficient to support
full transactivation of P38 by NS1
Previous analyses have suggested that the MVM P38
core promoter elements, the TATA motif and the Sp1-
binding site, as well as an upstream NS1-binding site,
are important cis signals for efficient transactivation of
P38 by NS1 (Ahn et al., 1992; Gavin and Ward, 1990; Gu
et al., 1992; Lorson et al., 1996; Storgaard et al., 1993;
Christensen et al., 1993). To determine whether these
core P38 promoter elements were alone sufficient to
mediate NS1 transactivation, the P38 Sp1-binding site,
TATA element, and putative initiator region (designated S,
T, and I, respectively) were introduced into the polylinker
of an otherwise heterologous plasmid backbone (see
Materials and Methods), in the same orientation and
spacing as they exist in their native contexts, either with
or without proximal upstream NS1-binding sites, and
assayed for activity following cotransfection with NS1.
In the presence of a 36-nt fragment from the MVM TAR
region (nt 1854–1891) containing the native NS1-binding
sites positioned 76 nt upstream of the isolated Sp1 and
TATA elements, the P38 core elements could be effi-
ciently transactivated by NS1, to levels greater than 60%
of that seen for wild-type P38 [Fig. 1A, pP38(TAR)S/
T(bGH)]. When the TAR-containing fragment was re-
placed with two synthetic NS1-binding motifs positioned
95 nt upstream of the isolated Sp1 and TATA elements,
the P38 core promoter elements were still transactivated
by NS1 dramatically relative to their basal activity, which
is essentially undetectable in this RNase protective as-
say (data not shown), to approximately one-third of wild-
type P38 transactivated levels [Fig. 1A, pP38(ACCA)4S/
T(bGH) and pP38(ACCA)4S/T/I(bGH)]. These results
demonstrate that the Sp1 and TATA elements alone are
sufficient to mediate nearly wild-type levels of transacti-
vated activity when NS1 is proximally targeted.
The difference between activation of constructs con-
taining the 36-nt TAR fragment and the synthetic NS1-
binding sites is most likely due to NS1’s reduced ability
to interact with the synthetic NS1-binding motifs. It is
unlikely that this difference is because this small region
binds a cellular factor that aids in transactivation of P38
because linker scanner mutations within this region that
fall outside of the NS1-binding site, as well as deletion of
the entire TAR element itself does not inhibit transacti-
vation of P38 in the context of the full length genome
(Lorson et al., 1996). It seems more likely that NS1 binds
the authentic TAR region better than the synthetic site in
vivo, perhaps in conjunction with additional cellular fac-
tors.
As expected, in the absence of proximal upstream
NS1-binding sequences, NS1 transactivation of the P38
core promoter elements was very low, amounting to less
than 5% of that seen for fully transactivated native P38
constructs [Fig. 1A, pP38S/T(bGH), pP38S/T/I(bGH)]. The
residual activity detected was probably a consequence
of downstream consensus NS1-binding motifs present
within the bGH sequences (Lorson et al., 1996). In the
absence of P38 core promoter elements expression was
not detectable following NS1 cotransfection (data not
shown).
In the context of the viral genome, NS1 can transacti-
vate P38 modestly in the absence of the proximal P38
Sp1 element (Lorson et al., 1996). As shown in Fig. 1A,
however, a minimal construct consisting only of a NS1-
binding site and the P38 TATA motif could be transacti-
vated by NS1 only to levels barely detectable by RNase
protection assay, i.e., less than 2% of wild-type [Fig. 1A,
pP38(ACCA)4T(bGH)], suggesting that the P38 Sp1 ele-
ment was necessary to support high levels of NS1 trans-
activation in these minimal constructs. These results
raise the possibility that other cis-elements in the viral
genome, including, perhaps, other known Sp1-binding
sites, may contribute to generating maximal transacti-
vated levels of the P38 promoter during infection, and
when these are absent, a greater dependence upon the
P38 Sp1 site is observed.
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Using a more sensitive luciferase assay, however, we
can also demonstrate that the P38 TATA element alone
undergoes a similar fold activation over its very low
basal level, when NS1 is proximally targeted to this motif
(Table 1). As described previously (Lorson et al., 1996;
Lorson and Pintel, 1997), the basal level of activity in the
absence of NS1 of a construct containing only the P38
TAR and TATA motif [pP38TarT(Luc)] is very low and
significantly less than a similar P38 construct that also
contains the Sp1 site [pP38TarS/T(Luc)]. When NS1 is
targeted proximally to these sequences, however, a sim-
ilar 10-fold activation over basal levels can be detected
for the two constructs in these assays. That targeted NS1
can efficiently enhance expression from a TATA motif
alone suggests that it may act directly to stimulate ac-
tivity of the basal transcription machinery.
NS1 has also been reported to have a modest stimu-
latory effect upon the already high basal level of activity
of the MVM P4 promoter (Ahn et al., 1989; Lorson and
Pintel, 1997; Doerig et al., 1990). As shown in Fig. 1B, the
P4 core promoter elements, when introduced into an
otherwise heterologous plasmid backbone in the same
FIG. 1. (A) Near wild-type levels of NS1 transactivation are supported by minimal promoter constructs composed exclusively of an upstream
NS1-binding motif and the MVM P38 Sp1 and TATA elements. Shown are expression levels of correctly initiated RNA from various P38(bGH) core
promoter element experimental templates, analyzed by RNase protection assays, using a bGH-specific probe as described under Materials and
Methods. Values are presented relative to the transactivated levels achieved by p1854-2072(bGH) cotransfected with the NS1-supplying plasmid
pKONS1m (Lorson et al., 1996). p1854-2072(bGH) P38 transactivated levels are at least as high as P38 transactivated levels from a full-length genomic
construct (Lorson et al., 1996; Lorson and Pintel, 1997) and are here set at 100%. Core P38 promoter elements (S, Sp1; T, TATA; I, Inr), synthetic
NS1-binding motifs, (ACCA)4, and native TAR sequences (MVM nts 1854 to 1891) are indicated. Quantitations and standardizations using a
cotransfected reported plasmid were performed as described under Materials and Methods. Average values from four separate experiments,
determined by RNase protections of 20 mg of total RNA isolated from A9 cells 48 h posttransfection are as follows (including 95% confidence limits);
pP38S/T, 3% 6 0.7; pP38S/T/I, 0.9% 6 0.7; pP38(ACCA)4S/T, 29% 6 4; pP38(ACCA)4S/T/I, 31% 6 3; pP38(TAR)S/T, 67% 6 9; pP38(ACCA)4T, ,1%. (B)
Synthetic promoters composed of MVM P4 core transcription regulatory motifs can be transactivated by NS1. Shown are P4 expression levels in A9
cells from various P4(Luc) core promoter element test templates, analyzed by luciferase expression as described under Materials and Methods. S,
T, and I correspond to the appropriate Sp1, TATA, or initiator elements from the P4 promoter, as described under Materials and Methods. The negative
control parent plasmid, lacking core promoter motifs, is pBasic(Luc). Luciferase values are presented relative to mock-transfected A9 extract; they
represent the average of four independent experiments and are as follows (including 95% confidence limits): pBasic, 18 6 4; pBasic 1 NS1, 19 6 3;
pP4S/T(Luc), 90 6 23; pP4S/T(Luc) 1 NS1, 103 6 43; pP4S/T/I(Luc), 82 6 34; pP4S/T/I(Luc) 1 NS1, 82 6 16; p(ACCA)4P4S/T(Luc), 91 6 20;
p(ACCA)4P4S/T(Luc) 1 NS1, 367 6 57; p(ACCA)4P4S/T/I(Luc), 89 6 45; p(ACCA)4P4S/T/I(Luc) 1 NS1, 374 6 75; pTARP4S/T(Luc), 122 6 50;
pP4TARP4S/T(Luc) 1 NS1, 555 6 156; pTARP4S/T/I(Luc), 127 6 32; pTARP4S/T/I(Luc) 1 NS1, 733 6 106.
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orientation and spacing as they exist in their native
contexts (the distance between the P4 Sp1 site and the
TATA element is 6 nts in the P4 promoter, as compared to
16 nts in P38), can also be activated by NS1. As expected,
in the absence of proximal upstream NS1-binding motifs,
NS1 failed to significantly activate minimal P4 constructs
[Fig. 1B, pP4S/T(Luc) and pP4S/T/I(Luc), 2/1 NS1]. How-
ever, upon the addition of synthetic NS1-binding sites,
NS1 was able to stimulate the minimal P4 constructs
approximately fourfold [Fig. 1B, p(ACCA)4P4S/T(Luc) and
p(ACCA)4P4S/T/I(Luc), 2/1 NS1]. Replacing the syn-
thetic (ACCA)4 motifs with the NS1-binding sites present
in the P38 TAR element (MVM nt 1854 to 1891) [Fig. 1B,
pTARP4S/T(Luc), pTARP4S/T/I(Luc), 1/2 NS1] resulted
in somewhat greater levels of transactivation by NS1, as
described above for the P38 core promoter constructs.
The four- to sixfold transactivation of the P4 core ele-
ments by NS1 is similar to that seen following NS1
activation of the native P4 promoter (Lorson and Pintel,
1997).
Since NS1 can transactivate an Sp1 and TATA element
as they exist naturally in either the P38 or P4 core
promoter elements, as well as chimeric promoters in
which the P38 Sp1 and TATA motifs had been replaced
with the analagous elements from the SV40 early pro-
moter (Lorson and Pintel, 1997), we conclude that the
specific sequence of these elements and the relative
distance between them is not critical for NS1 activation.
Different TATA sequence motifs are known to promote
the formation of different transcription complexes upon
various promoter regions (Orphanides et al., 1996), im-
plying that NS1 may exert its transactivation function
through a factor(s) common to these complexes.
The experiments thus far described demonstrate that
the Sp1 and TATA motifs are sufficient to mediate near
wild-type levels of NS1-transactivated expression when
an upstream NS1-binding site is present and suggest
that NS1 transactivation might be mediated through an
interaction(s) with Sp1 and components of the general
transcription machinery assembled at the various TATA
elements. The P38 TATA motif alone can undergoe a
similar fold activation by proximally targeted NS1, sug-
gesting the possibility that stimulation of the basal tran-
scription machinery may be the primary target of NS1
transactivation and that SP1 may act synergistically to
achieve the very high levels of expression seen in vivo.
NS1 interacts with Sp1 directly
Krady and Ward (1995) have previously shown that
NS1 and Sp1 can interact in a complex; however, their
work was performed prior to the demonstration that NS1
had sequence-specific DNA-binding activity. The identi-
fication of such an activity for NS1 by Cotmore, Chris-
tensen, and Tattersall (Cotmore et al., 1995; Christensen
et al., 1995), prompted us to reinvestigate the interaction
between NS1 and Sp1, and to do so we used a bacterially
produced GST–NS1 fusion protein that we have previ-
ously shown possesses authentic sequence-specific
DNA-binding capabilities (Lorson et al., 1996).
As can be seen in Fig. 2A, purified GST–NS1 can
efficiently capture endogenous Sp1 as it exists in a
transcriptionally competent murine extract that had been
pretreated with DNase and RNase. These results con-
firm those of Krady and Ward (1995) and further demon-
strate that NS1:Sp1 complexes can exist independently
of DNA. (These experiments certainly do not rule out the
possibility that NS1:Sp1 interactions could be facilitated
by DNA containing binding sites for both proteins.)
To examine this interaction further, in vitro binding
assays were developed. Purified GST–NS1 was incu-
bated with [35S]methionine-labeled Sp1 generated in a
coupled transcription and translation (TnT) reticulocyte
lysate system, and all assays were performed following
treatment of the binding constituents with DNase,
RNase, and 100 mg/ml of ethidium bromide. Initially a
saturatable, linear binding relationship was established
using increasing amounts of in vitro generated SP1 at a
low salt concentration (80 mM NaCl2) (data not shown).
At subsaturating concentrations, Sp1 was then shown to
interact with GST–NS1 over a broad salt gradient; bind-
ing was stable up to 320 mM NaCl2 (Fig. 2B, top). This
association was resistant to competition with the simple
competitor BSA, at both 100- and 1000-fold molar excess
FIG. 1—Continued
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relative to GST–NS1 (Fig. 2B, bottom, lanes 1–4). Proteins
present in a bacterial extract (complex competitor) could
reduce Sp1 binding to GST–NS1 at 1000-fold excess, but
significant association greater than that seen with GST
alone was still evident (Fig. 2B, bottom, lanes 5–8). In
addition, under subsaturating conditions the binding be-
tween NS1 and Sp1 was not enhanced by the further
addition of unprogrammed reticulocyte lysate, suggest-
ing that the interaction between the two proteins was
direct (data not shown). Similar interactions could be
demonstrated using the reciprocal partners, GST–Sp1
and in vitro transcribed and translated NS1 (data not
shown). These results demonstrated that bacterially pro-
duced NS1 can interact strongly independent of nucleic
acid bridging, and most likely directly with Sp1 in vitro,
and that NS1 can associate with endogenous Sp1 as it
exists in a transcriptional competant murine nuclear ex-
tract.
NS1 can interact with TBP and TFIIA in vitro
That a TATA sequence alone can be transactivated by
NS1 when targeted proximally to the area suggested that
NS1 may interact with members of the basal transcrip-
tion machinery. Therefore in vitro binding assays using
GST–NS1 and several TnT-generated cellular GTFs, in-
cluding TBP, TFIIA(a/b), TFIIA(g), TFIIB, TFIIF(RAP74),
and TFIIH(p62) were performed. Only specific interac-
tions between NS1 and TBP and TFIIA(a/b) were de-
tected, and these were examined further. As described
for Sp1, initial titration experiments revealed a saturat-
able, linear binding relationship between GST–NS1 and
increasing amounts of TnT-generated TBP or TFIIA(a/b)
in vitro (data not shown). NS1 associated with approxi-
mately 10% of either target, consistent with levels seen
for other well characterized binding partners (Johnston et
al., 1996). Binding in the presence of increasing salt
concentrations performed at subsaturating amounts of
TnT-derived TBP and TFIIA(a/b) was stable over a broad
salt gradient: TBP binding was reduced only at 320 mM
NaCl2 (Fig. 3B, top), while TFIIA(a/b) binding decreased
in a linear fashion above 80 mM NaCl2 (Fig. 3A, top). Both
interactions were resistant to competition by a simple
competitor, BSA, and a complex bacterial lysate (Figs. 3A
and 3B, bottom). These interactions, carried out in the
presence of DNase, RNase, and 100 mg/ml of ethidium
bromide, were resistant to competition with both com-
petitors at concentrations constituting a 100-fold molar
excess relative to GST–NS1. At 1000-fold excess of com-
plex inhibitor, binding decreased significantly below 10%
of input for TBP (Fig. 3B, bottom); however, binding of
TFIIA(a/b) to GST–NS1 remained largely unaffected un-
der these conditions (Fig. 3A, bottom).
TBP is a very basic protein and the amino- and car-
boxy-terminal portions of NS1 are of a highly acidic
nature. If the interaction between the two were due
exclusively to a nonspecific interaction dependent upon
charge, it would be expected that NS1 would interact
with denatured TBP as well as it interacts with the native
protein. Heat denaturation of TBP at 48°C has been
shown to abolish the transcriptional activity of TBP (Na-
kajima et al., 1988), and such treatment has been used
previously to assess the specificity of the interaction of
TBP with SV40 T-antigen (Johnston et al., 1996). Treat-
ment of TBP at 48°C prior to incubation with GST–NS1
substantially reduced the interaction of these proteins
(Fig. 3C, compare lanes 1 and 3), suggesting that the
native conformation of TBP was necessary for this spe-
cific association to occur.
Preliminary attempts to capture TBP and TFIIA(a/b)
from nuclear extracts with NS1 have not yet been suc-
cessful; however, the following points support the rele-
vance of these interactions with NS1: (i) the interactions
in vitro are stable in high salt: significant binding is
retained in 320 mM NaCl2 for TFIIA(a/b), and up to 800
mM KCl for TBP (data not shown), and binding is not
affected by treatment of the binding constituents with
DNase, RNase, or 100 mg/ml of ethidium bromide; (ii) the
interactions are quite stable to 1000-fold competition,
relative to GST–NS1, with both a simple and a complex
protein extract, which represents approximately 100,000-
fold excess over the in vitro synthesized GTF target
proteins; (iii) the interaction for TBP is dependent upon
the native tertiary conformation of TBP: mild heat treat-
ment known to disrupt the function of TBP (Johnston et
TABLE 1
Transactivation of Minimal P38 Promoter Constructs by NS1a
Experiment 1 Experiment 2
(2) NS1 (1) NS1 Fold activation (2) NS1 (1) NS2 Fold activation
pP38T(Luc) 61 183 3 65 226 3
pP38TarT(Luc) 30 334 11 40 384 10
pP38TarS/T(Luc) 189 1836 10 302 3532 12
pBasic(Luc) 62 103 2 298 348 1
a Transfection were done using 4 mg of target and 1 mg of NS1-supplying plasmid per 60-mm2 dish where indicated. Results are expressed in
relative luciferase units.
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al., 1996; Nakajima et al., 1988) dramatically decreases
association with NS1; and (iv) although we detect NS1
interactions with both TBP and TFIIA(a/b), NS1 fails to
interact specifically with a number of other GTF’s, includ-
ing TFIIA(g), TFIIB, TFIIF(RAP74), and TFIIH(p62).
We have also recently shown that the bovine papillo-
mavirus (BPV) E2 protein, a potent transcriptional activa-
tor (Breiding et al., 1996) that has a number of similarities
to NS1 [it is a sequence-specific DNA-binding protein
within the BPV long control region (Androphy et al., 1987),
and it directly interacts with a number of cellular tran-
scription factors, including Sp1 and TBP (Li et al., 1991)],
can efficiently transactivate the MVM P38 promoter when
it is targeted to these sequences by its binding site (C.
Lorson and D. J. Pintel, unpublished observations).
How does NS1 transactivate the P38 promoter
We have recently shown that the core promoter ele-
ments of P38, although able to direct only very low levels
of basal activity in vivo, are themselves intrinsically com-
petant transcription regulatory elements that can be
FIG. 2. (A) NS1 specifically interacts with Sp1 in transcriptionally active murine nuclear extracts. Capture assays from murine FM3A nuclear extracts
using GST–NS1 were performed following treatment with RNase and DNase as described under Materials and Methods. Samples were resolved on
10% SDS–PAGE, transferred to nitrocellulose, and immunoblotted with anti-SP1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) as described
under Materials and Methods. Lanes 1 and 2 show capture of endogenous Sp1 using glutathione-agarose beads loaded with GST alone or GST–NS1,
respectively. Lanes 3 and 4 show 1⁄5 of postbinding supernates (PBS) following capture with GST or GST–NS1, respectively. One-fifth of the nuclear
extract used for each capture assay, showing the endogenous levels of detectable Sp1, was run in lane 5. (B) Top: In vitro generated Sp1 interacts
with GST–NS1 over a broad ionic gradient. In vitro capture assays using in vitro-generated, [35S]methionine-labeled Sp1 were performed following
treatment with RNase, DNase, and 100 mg/ml ethidium bromide as described under Materials and Methods. Samples were run on a 10%
SDS–polyacrylamide gel. Lane 1 shows interaction with GST alone at 80 mM NaCl. Lanes 2–5 show Sp1 interaction with GST–NS1 at 80, 160, 240,
and 320 mM NaCl, respectively. Lane 6 shows 10% of the input in vitro-generated Sp1 used for each assay. Bottom: Sp1 interaction with NS1 is stable
to excess of both simple and complex competitors. In vitro capture assays using in vitro-generated, [35S]methionine-labeled Sp1 were performed in
the presence of simple (BSA) and complex (E. coli lysate) protein competitor at 125 mM NaCl following treatment with RNase, DNase, and 100 mg/ml
ethidium bromide as described under Materials and Methods. Samples were run on a 10% SDS–polyacrylamide gel. Lanes 1 and 5 show interaction
with GST alone. Lanes 2, 3, 6, and 7 show interaction with GST–NS1 and can be compared to lanes 2 and 6 in the top panel. Samples shown in lanes
1 and 2 were from capture assays performed in the presence of 100-fold excess BSA; those shown in lanes 5 and 6 were done in the presence of
100-fold excess E. coli lysate. Samples shown in lanes 3 and 7 were performed in the presence of 1000-fold excess BSA and E. coli lysate,
respectively. Lanes 4 and 8 represent 10% of the input in vitro-generated, [35S]methionine-labeled Sp1.
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FIG. 3. (A) Top: In vitro-generated TFIIA(a/b) interacts with GST–NS1 over a broad ionic gradient. In vitro capture assays using in vitro-generated,
[35S]methionine-labeleled TFIIA(a/b) were performed following treatment with RNase, DNase, and 100 mg/ml ethidium bromide as described under
Materials and Methods. Samples were run on a 10% SDS–polyacrylamide gel. Lane 1 shows interaction with GST alone at 80 mM NaCl. Lanes 2–5
show TFIIA (a/b) interaction with GST–NS1 at 80, 160, 240, and 320 mM NaCl, respectively. Lane 6 shows 10% of the input in vitro-generated TFIIA(a/b)
used for each assay. Bottom: TFIIA(a/b) interaction with NS1 is stable to excess of both simple and complex competitors. In vitro capture assays using
in vitro-generated, [35S]methionine-labeled TFIIA (a/b) were performed with the addition of simple (BSA) and complex (E. coli lysate) protein
competitor at 125 mM NaCl following treatment with RNase, DNase, and 100 mg/ml of ethidium bromide as described under Materials and Methods.
Samples were run on a 10% SDS–polyacrylamide gel. Lanes 1 and 5 show interaction with GST alone. Lanes 2, 3, 6, and 7 show interaction with
GST–NS1 and can be compared to lanes 2 and 6 in the top panel. Samples shown in lanes 1 and 2 were from capture assays performed in the
presence of 100-fold excess BSA, those shown in lanes 5 and 6 were done in the presence of 100-fold excess E. coli lysate. Samples shown in lanes
3 and 7 were from assays performed in the presence of 1000-fold excess BSA and E. coli lysate, respectively. Lanes 4 and 8 represent 10% of the
input in vitro-generated, [35S]methionine-labeled TFIIA(a/b). (B) Top: In vitro-generated TBP interacts with GST–NS1 over a broad ionic gradient. In
vitro capture assays using in vitro-generated, [35S]methionine-labeled TBP were performed following treatment with RNase, DNase, and 100 mg/ml
of ethidium bromide as described under Materials and Methods. Samples were run on a 10% SDS–polyacrylamide gel. Lane 1 shows interaction with
GST alone at 80 mM NaCl. Lanes 2–5 show TBP interaction with GST–NS1 at 80, 160, 240, and 320 mM NaCl, respectively. Lane 6 shows 10% of the
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stimulated by enhancer sequences added in cis (Lorson
and Pintel, 1997). Additionally, in murine and human
nuclear extracts, efficient transcription in vitro of depro-
teinized P38 templates does not require NS1; P38 activity
under these conditions is stronger than that seen for the
MVM P4 promoter and is similar to that seen for the
adenovirus major late promoter (Pintel et al., 1983) (C.
Lorson and D. J. Pintel, unpublished observations).
These observations suggest that the role of NS1 may be
to relieve a conformational constraint on P38 seen in
vivo, to counteract a repressing factor lost in the gener-
ation of transcription extracts, or to increase the local
concentration of a general transcription factor whose
concentration in an extract may not be limiting, or a
combination of any or all of these effects. It seems
unlikely that NS1 acts to counteract the effects of a
negative regulator. Extensive mutational analysis has not
resulted in increased basal expression of P38 (Lorson et
al., 1996; Lorson and Pintel, 1997) (C. Lorson and D. J.
Pintel, unpublished observations), and various TATA–Sp1
combinations, in otherwise heterologous backgrounds,
can be transactivated when NS1 is directed to promoter
proximal sequences, implying that a repressing factor
would have to be common to complexes forming at
various TATA motifs. It seems more likely that the role of
NS1 involves direct interaction with Sp1 or a GTF, which
may modify or recruit one or more of these factors or
their interacting partners such as the TAFs. Alternatively,
or additionally, the role of NS1 may be to open or alter the
structure of the template in a favorable way, which may
be required since there are no functional enhancer se-
quences immediately upstream of P38 as there are for
P4. It is interesting in this regard that when targeted
upstream, NS1 can efficiently activate a TATA element
alone. These results suggest that while Sp1 is required
to achieve full transactivated P38 activity, it may be act-
ing synergistically rather than being the primary target of
NS1 transactivation.
The MVM P4 promoter has high constitutive activity
because of its upstream enhancer-binding sites (Ahn et
al., 1989; Faisst et al., 1994; Fuks et al., 1996; Gu et al.,
1995; Lorson and Pintel, 1997). We have recently shown
that although such enhancer sequences can activate
P38 in minimal constructs in vivo, to levels approaching
that seen following NS1 transactivation, these enhancer
sequences, when placed proximally to P38, cannot acti-
vate it in the context of the complete viral genome (Lor-
son and Pintel, 1997). The requirement of P38 for NS1 is,
therefore, an efficient means to delay the expression of
the capsid-encoding genes until after the initiation of
expression of the nonstructural genes during viral infec-
tion.
MATERIALS AND METHODS
Cells and transfections
Murine A92L cells were propagated as described pre-
viously (Tullis et al., 1988). Transient transfections were
performed with DEAE-dextran or CaCl2 as described
previously (Schoborg and Pintel, 1991). Where indicated,
NS1 was supplied with the plasmid pKONS1m (Lorson et
al., 1996), from which NS1 expression is driven by the
SV40 early promoter. Within this construct, the nucleo-
tides between 2016 and 2047 have been altered such
that degenerate changes were introduced into the NS1
(and NS2) open reading frames. These alterations al-
lowed us to differentiate between mRNAs generated
from test plasmids and those RNAs deriving from the
NS1-supplying cotransfected plasmid by RNase protec-
tion assay and was therefore used to standardize trans-
fection efficiencies in experiments presented in Fig. 1A
and Fig. 1B.
Plasmid constructs
P38-bGH cassette construct and pGL2-based Luc and
bGH reporter constructs. p1854-2072(bGH) contains
MVM nt 1854 to 2072, cloned immediately upstream of
the bovine growth hormone gene, bGH, and is transac-
tivated by NS1 to wild-type levels (Lorson et al., 1996;
Lorson and Pintel, 1997). P4 and P38 constructs were
cloned into either the pGL2-basic plasmid polylinker se-
quence (Promega, Madison, WI), driving expression of
the luciferase gene, or into the polylinker of a derivative
of pGL2-basic, pGL2-bGH, in which we replaced the
luciferase gene with the genomic sequence of the bovine
input in vitro-generated TBP used for each assay. Bottom: TBP interaction with NS1 is stable to excess of both simple and complex competitors. In
vitro capture assays using in vitro-generated, [35S]methionine-labeled TBP were performed with the addition of simple (BSA) and complex (E. coli
lysate) protein competitor at 125 mM NaCl following treatment with RNase, DNase, and 100 mg/ml of ethidium bromide as described under Materials
and Methods. Samples were run on a 10% SDS–polyacrylamide gel. Lanes 1 and 5 show interaction with GST alone. Lanes 2, 3, 6, and 7 show
interaction with GST–NS1 and can be compared to lanes 2 and 6 in the top panel. Samples shown in lanes 1 and 2 were from capture assays
performed in the presence of 100-fold excess BSA, those shown in lanes 5 and 6 were done in the presence of 100-fold excess E. coli lysate. Samples
shown in lanes 3 and 7 were performed in the presence of 1000-fold excess BSA and E. coli lysate, respectively. Lanes 4 and 8 represent 10% of the
input in vitro-generated, [35S]methionine-labeled TBP. (C). TBP interaction with GST–NS1 is abolished by pretreatment of TBP at 48°C. In vitro capture
assays were performed using GST–NS1 (lanes 1 and 3) or GST alone (lanes 2 and 4) in 80 mM NaCl as described under Materials and Methods,
with in vitro-generated, [35S]methionine-labeled TBP, either following treatment of TBP at 48°C (lanes 3 and 4) or without prior treatment (native, lanes
1 and 2). Lanes 5 and 6 show 10% of the input in vitro-generated TBP used in each assay, either following heat treatment (lane 6) or without prior
treatment (native, lane 5). Samples were run on a 10% polyacrylamide gel.
333MVM P38 TRANSACTIVATION
growth hormone (Lorson et al., 1996; Lorson and Pintel,
1997). The following suffixes are used to denote the
identity of each expression plasmid backbone: (Luc) de-
notes pGL2-basic, (bGH) denotes pGL2-bGH. As de-
scribed below, ‘‘Luc’’ constructs were used in luciferase
assays, and ‘‘bGH’’ constructs were used in RNase pro-
tection assays. All pGL2(bGH) and pGL2(Luc) [also re-
ferred to as pBasic(Luc)] derivative constructs contain an
additional poly(A) signal immediately upstream of the
promoter constructs described in the text, which serves
to reduce the level of nonspecific background
readthrough.
Isolated core promoter constructs. pP4S/T(Luc), which
contains the MVM P4 Sp1 site and TATA box (underlined
below), was created by annealing the following comple-
mentary single-stranded oligonucleotides: 59-CTAGCT-
GGGCGTGGTCCATGGTATATAATC-39 (top), 59-TCGAGA-
TTATATACCATGGACCACGCCCA-39 (bottom). When an-
nealed, the double-stranded substrate contains compat-
ible cohesive 59 and 39 ends, which allows this fragment
to be directionally cloned between the NheI and XhoI
sites within the pGL2-Luc polylinker. pP38S/T(bGH),
which contains the MVM P38 Sp1 site and TATA box
(underlined below), was created by annealing the follow-
ing complementary single-stranded oligonucleotides:
59-CTAGCTGGGCGGAGCATCGTCCATGGAGCGATA-
TAAATTC-39 (top), 59-TCGAGAATTTATATCGCTCCATG-
GATGGACGATGCTCCGCCCAGG-39 (bottom). This dou-
ble-stranded substrate also contains 59 and 39 ends
compatible with NheI and XhoI generated ends and was
cloned between the NheI and XhoI sites within the pGL2-
bGH polylinker. The flanking and intervening sequences
are heterologous, but the nucleotide spacing between
the Sp1 and TATA elements is identical to the native
promoter spacing (6 nt at P4, and 16 nt at P38). The
Initiator elements (Inr) were introduced using comple-
mentary single-stranded oligonucleotides containing 13
MVM nts spanning the RNA initiation site of either P4 or
P38 (underlined below). To generate pP4S/T/I(Luc), oli-
gonucleotides 59-TCGAGTTCGCGTTCAGTTACTTATCA-
39 (top) and 59-GATCTGATAAGTAACTGAACGCGAAC-39
(bottom) were annealed and ligated into pP4S/T(Luc) at
the XhoI and BglII sites in the polylinker. To generate
pP38S/T/I(bGH), oligonucleotides 59-TCGAGTTCGCGT-
GTCCGCTCACCATTCACA-39 (top) and 59-GATCTGT-
GAATGGTGAGCGGACACGCGAAC-39 (bottom) were an-
nealed and ligated between the XhoI and BglII sites of
pP38S/T(bGH). The P4 and P38 RNA initiation site within
the Inr elements (underlined) was positioned such that
the distance from the TATA element within pP4S/T/I(Luc)
and pP38S/T/I(bGH) was the same as in the native pro-
moter contexts; however, the intervening sequence is
heterologous. Sequence inspection revealed that the in-
tervening sequences did not introduce any known bind-
ing elements for additional factors. (b) pP38(ACCA)4S/
T(bGH) and pP38(ACCA)4S/T/I(bGH) were constructed
using pP38S/T(bGH) and pP38S/T/I(bGH), respectively,
by cloning the following synthetic NS1 DNA-binding mo-
tifs [(59-ACCAACCAA-39)4 (Lorson et al., 1996)] 95 nts
upstream of the Sp1 elements in either parent construct.
p(ACCA)4P4S/T(Luc) and p(ACCA)4P4S/T/I(Luc) were
constructed by cloning the same (ACCA)4-containing
fragment 95 nucleotides upstream of the Sp1 elements in
the parent constructs pP4S/T(Luc) and pP4S/T/I(Luc).
pP38(ACCA)4T(bGH) was created by deleting 20 nts en-
compassing the synthetic SP1 site from pP38(ACCA)4
S/T(bGH). pP38(TAR)S/T(bGH), pTARP4S/T(Luc), and
pTARP4S/T/I(Luc) were created using pP38S/T(bGH),
pP4S/T(Luc), and pP4S/T/I(Luc), respectively, by cloning
the native P38 TAR element (MVM nt 1854 to 1886) 76
nucleotides upstream of the respective Sp1 sites.
pP38TarS/T(Luc) was created by replacing the bGH gene
in pP38(TAR)S/T(bGH) with the luciferase gene.
pP38TarT(Luc) contains the native TAR element (nt 1854–
1886) positioned 92 nts upstream of the P38 TATA ele-
ment (T), which is the same distance that these two
elements are positioned in the pP38(TAR)S/T(bGH) plas-
mid. pP38T(Luc) contains only the P38 TATA element,
upstream of the luciferase gene. To create pP38T(Luc),
MVM sequences upstream of the TATA motif were de-
leted from pP38S/T(Luc), which has been previously de-
scribed (Lorson and Pintel, 1997).
RNA isolation and characterization
Total RNA was isolated and Northern blots and RNase
protection assays were performed with MVM-specific
probes as described previously (Tullis et al., 1993; Nae-
ger et al., 1992; Lorson et al., 1996), allow for compari-
sons between correctly initiated RNA species. Quantita-
tions were performed on a Molecular Dynamics
Phosphor-Imager. pKONS1m was constructed such that
when the wild-type MVM HaeIII probe (nt 1854 to 2378)
was used for RNase protections, the nucleotide alter-
ations of pKONS1m (MVM nt 2016 to 2046) generated a
specific 234-bp breakdown product (nt 2046 to 2280)
which could be quantitated. This allowed us to differen-
tiate between transcripts originating from experimental
templates and those from the cotransfected NS1-supply-
ing plasmids. Quantitation of the relative accumulation of
this RNA species, present in all cotransfected experi-
ments, permitted the standardization of transfection effi-
ciencies and allowed comparison of expression plas-
mids that contain the bGH reporter, since in all instances
an equivalent amount of pKONS1m DNA was cotrans-
fected.
For the experiments shown in Fig. 1A, RNAs generated
by pP38(TAR)S/T(bGH) were first protected with a homol-
ogous probe that spanned the RNA initiation site. This
probe detected no readthrough transcript that had
evaded the poly(A) signal upstream of the promoter
present in the pGL-2 basic parent plasmid. This allowed
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the use of a single internal bGH probe for quantitation
and more accurate comparison of RNAs generated by all
mutants. The bGH RNase protection probe used was an
internal 338-bp bGH PstI fragment that spans the 59 end
of exon 1 to the 59 end of exon 4 (Hampson et al., 1989),
cloned into the PstI site of the pGEM3Z (Promega)
polylinker. The P38 values were adjusted for their relative
transfection efficiencies by the relative accumulation of
the pKONS1m product, as described above, for experi-
ments presented in Fig. 1A (Lorson et al., 1996).
Luciferase assays
For the experiments shown in Fig. 1B, 1 3 106 A92L
cells, in a 60-mm dish, were transfected with 1 mg of
template DNA. Forty eight hours posttransfection whole
cell extracts were prepared using the Triton X-100 basic
protocol and assayed as described (Brasier, 1990). Val-
ues shown represent four individual transfection exper-
iments. When indicated, the NS1-supplying plasmid
pKONS1m (Lorson et al., 1996) was cotransfected at 0.25
mg/60-mm dish. A titration experiment indicated that this
ratio was the minimal concentration which induced the
maximal level of p1854-2072(Luc) expression. Values in
the absence of extract were routinely approximately 10
relative luciferase units.
In vitro T7 transcription templates
pcDNA (Invitrogen, Carlsbad, CA) constructs contain-
ing TBP, TFIIA(a/b), TFIIA(g), TFIIB, TFIIE(p56), and TFI-
IF(RAP74) were a generous gift from K. Clemens (George
Washington University). An Sp1-expressing construct
was a generous gift from Dave Ward (Yale University).
Proteins
GST–NS1 was purified from BL21(DE3)pLysS Esche-
richia coli transformed with the plasmid pGEX-2TK-NS1
(Lorson et al., 1996). Following a 2.5-h induction with 0.5
mM IPTG, cells were pelleted and resuspended in lysis
buffer (50 mM Hepes, pH 7.5, 250 mM NaCl2, 0.5% NP-
40). After three freeze/thaw cycles, the lysate was briefly
sonicated followed by centrifugation at 10K for 30 min.
The supernatant from this spin was then centrifuged at
100K for 1 h to remove nonsoluble aggregates. This
cleared lysate was then incubated with glutathione-
linked agarose beads for 1 h at 4°C on a rotator. The
beads were washed extensively in lysis buffer to yield
purified NS1. Concentrations and purity of glutathione–
Sepharose-purified fusion proteins were estimated fol-
lowing sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) analysis, followed by Coo-
massie brilliant blue staining.
Radiolabeled proteins were synthesized in vitro using
the Promega coupled T7-transcription/translation kit in
rabbit reticulocyte lysates (Promega) with [35S]methi-
onine (Amersham, Arlington Heights, IL).
Binding assays
All in vitro binding experiments used approximately
300 ng of purified GST–NS1 on 10 ml of glutathione
agarose beads (Sigma, St. Louis, MO) in 300 ml of bind-
ing buffer (25 mM Hepes, pH 7.5, 0.25% NP-40, 10%
glycerol, 0.5 mM EDTA, 10 mm ZnSO4, 10 mM MgCl2, 0.5
mM DTT, 10 Mm ZnCl2, 100 mg/ml ethidium bromide, with
variable NaCl2 concentrations) and 1–2 ml of [
35S]methi-
onine-labeled Sp1, TBP, or TFIIA(a, b), generated in vitro
using a T7-coupled transcription/translation system.
Binding reactions were performed at 4°C for 1 h on a
rotator. Bound proteins were washed in 1 ml binding
buffer three times for 20 min, eluted by boiling in IP dye,
and resolved on a 10% SDS–PAGE gel. The gel was
flourographed and 35S-labeled proteins were detected by
autoradiography. In binding experiments involving salt
gradients (Figs. 2B, 3A, and 3B, top) the binding reaction
and the washing conditions contained the salt concen-
tration indicated. Binding experiments involving protein
competitor were performed at 125 mM NaCl2, at 100-fold
(0.1 mg/ml) and 1000-fold (1.0 mg/ml) excess, relative to
GST–NS1, of BSA (simple competitor) or E. coli lysate
(complex competitor), as indicated. E. coli competitor
lysate was generated from BL21(DE3)pLysS following
the above-mentioned protocol followed by treatment with
DNase1 and RNaseA prior to use as competitor. The
efficiency of nucleic acid removal was determined by
ethidium bromide staining following electrophoresis and
found to be .99%. In order to further exclude residual
nucleic acid involvement, 100 mg/ml ethidium bromide
was also added to all binding reactions (Lai and Herr,
1992). Bovine serum albumin (BSA) was purchased from
Sigma. To heat denature TBP, the T7-generated transla-
tion lysate was preincubated at 48°C for 15 min, which
has previously been described as being sufficient to
disrupt the native conformation of TBP (Johnston et al.,
1996; Nakajima et al., 1988).
Capture assays from nuclear extracts were performed
using 3 mg of purified GST–NS1 on 25 ml of beads,
incubated with 1 mg of a Dnase- and Rnase-treated
transcriptionally competent murine FM3A nuclear extract
[prepared as in (Dignam et al., 1983) and assayed using
the MVM P38 promoter], in 200 ml of extract binding
buffer (10 mM Hepes, pH 7.9, 20% glycerol, 50 mM KCl2,
0.6 mM EDTA, 10 mM ZnSO4, 10 mM MgCl2, 0.5 mM DTT,
10 mM ZnCl2), and rotated at 4°C. for 1 h. The efficiency
of nucleic acid removal, monitored as described above,
was found to be .99%. The bound proteins were washed
three times with 1 ml of WB-80 (25 mM Hepes, pH 7.5, 80
mM NaCl2, 0.25% NP-40, 10% glycerol, 0.5 mM EDTA, 10
mM ZnSO4, 10 mM MgCl2, 0.5 mM DTT, 10 mM ZnCl2).
Bound proteins were eluted by boiling in an SDS, DTT,
dye solution and resolved on a 10% SDS–PAGE gel.
Proteins were transferred to nitrocellulose and Western
blot analysis was performed with anti-Sp1 antibody
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(Santa Cruz Biotechnology, Santa Cruz, CA) followed by
detection with enhanced chemiluminescence (Amer-
sham).
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